The authorization of a $4 billion share repurchase program by Thermo Fisher Scientific suggests the company is confident in its financial position and is focused on returning value to shareholders. This is likely to have a positive impact on the stock price as it reduces the number of shares outstanding, potentially increasing earnings per share and making the stock more attractive to investors.